InvestorsHub Logo
Followers 0
Posts 39
Boards Moderated 0
Alias Born 02/02/2021

Re: None

Wednesday, 02/03/2021 12:19:32 PM

Wednesday, February 03, 2021 12:19:32 PM

Post# of 106837
USRM .054 wall to dump back to sub .03.

Fundamentally flawed USRM has no direction in the arena of stem cells other than they may have done some research back in the day. Maybe the initials should stand for U.S. Regenerative Medicine. They’ve lost their grip on the stem cell market, so they’re throwing in procedures like laser therapy and NAD injections which are not for low, mid or large cap companies.. cause there’s no large market. No plan exists to turn this company a profit and the accountants just keep slapping on that ‘going concern’ in every audit.